SCHEMBL1500282

SCHEMBL1500282

N#CCCOP(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11369620 0.84
SCHEMBL10344679 0.83 ALDH1A1 (0.37)
Pyrrolidine SCHEMBL28332115 0.83 POLB (0.34)
SCHEMBL1402719 0.83 TDP1 (0.31)
SCHEMBL3503384 0.80
SCHEMBL9436380 0.79
SCHEMBL13497373 0.79
SCHEMBL9113963 0.79
SCHEMBL8608523 0.79
SCHEMBL55354 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7160680-B2 Mutation analysis by mass spectrometry using photolytically cleavable primers BRUKER SAXONIA ANALYTIK GMBH (DE) 2007-01-09 US claimed
US-20020187493-A1 Mutation analysis by mass spectrometry using photolytically cleavable primers BRUKER SAXONIA ANALYTIK GMBH (DE) 2002-12-12 US claimed
EP-1234888-A2 Mutation analysis by mass spectrometry using photolytically cleavable primers BRUKER-SAXONIA ANALYTIK GMBH (DE) 2002-08-28 EP claimed
US-12595482-B2 Linkage modified oligomeric compounds and uses thereof IONIS PHARMACEUTICALS, INC. (US) 2026-04-07 US disclosed
US-20250368995-A1 Linkage Modified Oligomeric Compounds and Uses Thereof IONIS PHARMACEUTICALS, INC. (US) 2025-12-04 US disclosed
US-20250215040-A1 METHOD AND COMPOUND ATDBio Limited (GB) 2025-07-03 US disclosed
CN-119569609-B Method and device for recycling 3-hydroxypropionitrile in wastewater 山东海科创新研究院有限公司 2025-05-13 CN disclosed
CN-119569609-A Method and device for recycling 3-hydroxypropionitrile in wastewater 山东海科创新研究院有限公司 2025-03-07 CN disclosed
US-20250042932-A1 METHOD FOR PRODUCING POLYNUCLEOTIDES ATDBio Limited (GB) 2025-02-06 US disclosed
CN-119173522-A Methods and compounds ATD生物有限公司 2024-12-20 CN disclosed
CN-118339173-A Method for preparing polynucleotide ATD生物有限公司 2024-07-12 CN disclosed
WO-1993024634-A1 DIPEPTIDYL PEPTIDASE-I, CLONING IT, AND THERAPEUTIC AGENTS CONTAINING INHIBITORS THEREOF BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-12-09 WO disclosed
WO-1993012135-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1993-06-24 WO disclosed
WO-1993010820-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1993-06-10 WO disclosed
WO-1993009127-A1 ENHANCED TRIPLE-HELIX FORMATION DIRECTED BY OLIGONUCLEOTIDES COMPOSED OF 2'-DEOXY-7-DEAZAXANTHOSINE AND 2'-DEOXY-7-DEAZAGUANOSINE AND RELATED ANALOGS GILEAD SCIENCES, INC. (US) 1993-05-13 WO disclosed
EP-0539371-A1 TRIPLE HELIX FORMATION IN OLIGONUCLEOTIDE THERAPY GILEAD SCIENCES, INC. (US) 1993-05-05 EP disclosed
WO-1992010590-A1 INHIBITION OF TRANSCRIPTION BY FORMATION OF TRIPLE HELIXES GILEAD SCIENCES, INC. (US) 1992-06-25 WO disclosed
WO-1991006626-A2 TRIPLE HELIX FORMATION IN OLIGONUCLEOTIDE THERAPY GILEAD SCIENCES, INC. (US) 1991-05-16 WO disclosed
EP-0313219-A2 Non-nucleotide linking reagents for nucleotide probes GEN-PROBE INCORPORATED (US) 1989-04-26 EP disclosed
WO-1989002439-A1 NON-NUCLEOTIDE LINKING REAGENTS FOR NUCLEOTIDE PROBES ML TECHNOLOGY VENTURES, L.P. (US) 1989-03-23 WO disclosed